Archived explainer. For the current picture see today's AGL page.
Why Is AGILON HEALTH INC (AGL) Stock Down Today?
By the Top Tier Newswire AI Desk · November 18, 2026 at 11:07 AM ET · reviewed against 3 wire stories
AGILON HEALTH INC (AGL) is down -15.14% in the latest session. Our newswire has captured 3 stories on AGL across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 49/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Agilon Health (AGL) shares fell 15.14% to $97.76, driven by a new analyst rating that questions the durability of recent margin improvements. The stock opened at $115.20 and traded down to a session low of $97.38 by 11:05 AM ET.
What Happened
An analyst rated Agilon Health a Hold with a $98 price target, which sits 14.6% below the previous close of $114.81. The report argued that risk-score-driven margin gains in 2026 may not be sustainable. The firm noted that while the company is driving performance at scale through technology-enabled clinical programs, the underlying risk scores appear thinner than previously modeled. Truist reiterated a Hold rating on the stock with a $112 price target. The company also published a slide deck highlighting its technology-enabled clinical and quality programs on November 17, 2026.
What The Data Shows
The stock printed a fresh 52-week high and 15 fresh 52-week lows on November 18, 2026. The 52-week range spans from $7.48 to $133.04. Agilon Health has a market capitalization of $2.0B and remains unprofitable, with trailing twelve-month earnings per share of -$6.37. Revenue grew 2.0% over the trailing twelve months, while the net margin stood at -1.5%. The stock carries a beta of 3.11. Volume so far in the session is 0.1M shares, which is 0.2x the 3-month daily average. Sentiment has deteriorated, with the 7-day average lower than the 30-day average.
What To Watch
Agilon Health is scheduled to host a virtual investor event on November 17, 2026. Investors will monitor how the company addresses the concerns regarding risk score sustainability and margin durability following the recent rating changes.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Truist reiterates agilon health stock Hold rating at $112 target
Truist reiterates agilon health stock Hold rating at $112 target
2d agoSeeking AlphaBULLISH 56Product/PR
agilon health, inc. (AGL) Driving Performance at Scale: Technology-Enabled Clinical and Quality Programs - Slideshow
2026-11-17. The following slide deck was published by agilon health, inc.
3d agoSeeking AlphaBEARISH 42Analyst
agilon health: Same Doctors, Higher Risk Scores, Thinner Reserve
Analyst rates Agilon Health a Hold with a $98 target, 14.6% below its $114.81 close, as risk-score-driven 2026 margin gains may not last.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →